The IB Asia Pacific Healthcare Fund II Seeks to Invest in;

Entities in the Healthcare & Medical Science sector:

• The Fund will assess companies in the fields of Heathcare, Life Science, Hospital Serivices, Contract Research Organistions /  Serivice Providers and other health related auxillary entities.

Entities in the Asia Pacific Region:

• The Fund would assess companies domicilied in, or have a tangible link with Australia, New Zealand, Singapore, Mainland China, India, Indonesia, Vietnam, Malaysia, Thailand, the Republic of Korea, Hong Kong, Taiwan and Japan.

Proprietary technologies with international relevance:

• The Fund seeks globally relevent business and technologies, that have broader application than its domestic market,
• The Fund will consider investment into entities that seek to expand into new jurisdictions,
• The asset will usually be globally relevent.

Identified exit opportunities:

• The ability for Trade sale, Merger or Quotation of the entities securities on a globally relevent stock exchange must be present,
• An exit horizon of 3-5 years.

A strong IP position:

• All intellectual property must be relevent and unencumbered,
• Patents should be validated.

Programmes in clinical development or generating revenue:

• The technology or assets must be in human clinical trials or in the revenue-growth phase,
• Preclinical evaluation and blueprinting should be completed.